Pathology of advanced primary breast carcinoma.
作者： Fattaneh A. Tavassoli
DOI: 10.1016/S1055-3207(18)30419-8
关键词:
摘要: For a majority of women with breast carcinoma, the clinical course disease is determined by tumor size and axillary node metastases. Tumor type grade are also important prognostic factors. Estrogen progesterone receptor statuses good predictors likelihood response to hormone therapy survival. Patients high S-phase fraction at increased risk for early relapse. As far as other markers concerned, sufficient information not available currently make definitive decisions regarding inclusion their assessment in routine evaluation carcinomas.
sci-hub.se 参考文章(39)
Jerry L. Barker, Eleanor D. Montague, Lester J. Peters, Clinical experience with irradiation of inflammatory carcinoma of the breast with and without elective chemotherapy Cancer. ,vol. 45, pp. 625- 629 ,(1980) , 10.1002/1097-0142(19800215)45:4<625::AID-CNCR2820450402>3.0.CO;2-V
R Bettelheim, H G Penman, H Thornton-Jones, A M Neville, Prognostic significance of peritumoral vascular invasion in breast cancer British Journal of Cancer. ,vol. 50, pp. 771- 777 ,(1984) , 10.1038/BJC.1984.255
JM Bhatavdekar, DD Patel, NH Karelia, HH Vora, N Ghosh, NG Shah, DB Balar, SN Trivedi, Tumor markers in patients with advanced breast cancer as prognosticators: a preliminary study. Breast Cancer Research and Treatment. ,vol. 30, pp. 293- 297 ,(1994) , 10.1007/BF00665970
H J G Bloom, Further studies on prognosis of breast carcinoma. British Journal of Cancer. ,vol. 4, pp. 347- 367 ,(1950) , 10.1038/BJC.1950.34
H J G Bloom, Prognosis in carcinoma of the breast. British Journal of Cancer. ,vol. 4, pp. 259- 288 ,(1950) , 10.1038/BJC.1950.26
Ernest Camp III, None, Inflammatory carcinoma of the breast: the case for conservatism. American Journal of Surgery. ,vol. 131, pp. 583- 586 ,(1976) , 10.1016/0002-9610(76)90017-9
Paulo C. Cardoso de Almeida, Cynthia B. Pestana, Immunohistochemical markers in the identification of metastatic breast cancer. Breast Cancer Research and Treatment. ,vol. 21, pp. 201- 210 ,(1992) , 10.1007/BF01975003
Christine L. Carter, Carol Allen, Donald E. Henson, Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases Cancer. ,vol. 63, pp. 181- 187 ,(1989) , 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H
Frederic Clayton, Charlotte Lynn Hopkins, Pathologic correlates of prognosis in lymph node-positive breast carcinomas. Cancer. ,vol. 71, pp. 1780- 1790 ,(1993) , 10.1002/1097-0142(19930301)71:5<1780::AID-CNCR2820710512>3.0.CO;2-2
Ben W Davis, Richard Gelber, Aron Goldhirsch, William H Hartmann, Linda Hollaway, Ian Russell, CM Rudenstam, Ludwig Breast Cancer Study Group, Prognostic significance of peritumoral vessel invasion in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis Human Pathology. ,vol. 16, pp. 1212- 1218 ,(1985) , 10.1016/S0046-8177(85)80033-2